Bayer (United States)
In research, Bayer (United States) stands highest in Medicine (#3,267 of 10,443 worldwide), Health Sciences (#4,200 of 11,982 worldwide) and Life Sciences (#4,648 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Plant Science and Pulmonary and Respiratory Medicine — Plant Science is 5.8× its share of world research.
- World rank, 2022–2025
- #8,269 of 28,054 · #4,297 all time
- Rank in United States
- #1,103 of 4,192
- Research works
- 2.8k ▼ 4% vs 2013–17
- Citations
- 88k 31.1 per fractional work
- Top-10% rate
- 17.8% record average 16.5%
- Open access
- 34% world 28%
What is Bayer (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #3,267 of 10,443 | 15.6% | 139 | #1513 | |
| Health SciencesDomain | #4,200 of 11,982 | 15.6% | 149 | #1682 | |
| Life SciencesDomain | #4,648 of 7,800 | 27.8% | 114 | #3190 | |
| Physical SciencesDomain | #11,648 of 12,888 | 9.2% | 64 | #6640 |
Each strip is that field’s whole ranked pool, with the notch where Bayer (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#1,513 #3,267
- Health Sciences#1,682 #4,200
- Life Sciences#3,190 #4,648
- Physical Sciences#6,640 #11,648
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Bayer (United States) specialise in?
Where its research is concentrated relative to its size: Plant Science takes 5.8× the share of its output that it takes of world research.
- Plant ScienceSubfield · 37.2 works5.8×
- Pulmonary and Respiratory MedicineSubfield · 27.3 works4.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Agricultural and Biological Sciences, 3.4×. Every wedge is a field page.
- Agricultural and Biological Sciences 3.4×
- Biochemistry, Genetics and Molecular Biology 2.4×
- Medicine 2.0×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Economics, Econometrics and Finance 1.8×
- Mathematics 1.2×
- Nursing 1.0×
- Immunology and Microbiology 0.9×
- Decision Sciences 0.9×
- Environmental Science 0.8×
- Health Professions 0.8×
- Chemistry 0.7×
- Business, Management and Accounting 0.6×
- Arts and Humanities 0.5×
- Veterinary 0.5×
- Computer Science 0.4×
- Engineering 0.4×
- Neuroscience 0.3×
- Physics and Astronomy 0.3×
- Psychology 0.3×
- Dentistry 0.2×
- Materials Science 0.2×
- Social Sciences 0.2×
- Earth and Planetary Sciences 0.1×
- Chemical Engineering 0.1×
- Energy 0.1×
Who are the top researchers at Bayer (United States)?
Ranked on the composite score, D. Voliotis, Marc Fellous and Barrett H. Childs lead among researchers whose main affiliation is Bayer (United States).
- 1 D. Voliotis United States · #83,980 worldwide 1.4k citations · 23 works
- 2 Marc Fellous United States · #115,450 worldwide 185 citations · 27 works
- 3 Barrett H. Childs United States · #257,906 worldwide 118 citations · 28 works
- 4 J. Garcia‐Vargas United States · #322,899 worldwide 68 citations · 21 works
- 5 Sheldon X. Kong United States · #356,830 worldwide 124 citations · 16 works
- 6 Vijay N. Joish United States · #362,466 worldwide 90 citations · 24 works
- 7 Joachim Rudolph United States · #392,957 worldwide 118 citations · 23 works
- 8 Theodore E. Spiro United States · #450,320 worldwide 75 citations · 17 works
- 9 Carol E. Peña United States · #477,356 worldwide 83 citations · 29 works
- 10 Larry P. Sheets United States · #501,504 worldwide 52 citations · 16 works
Which keywords describe research at Bayer (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Clinical Trials, Biomarkers, Prostate Cancer, Genomic Profiling, Immunotherapy, Hormone Therapy, Genetic Mutations and Androgen Receptor.
- Marker-Assisted Selection
- Biotechnology
- BRAF Mutation
- Dosimetry
- Bacillus thuringiensis
- Insecticide Resistance
- RNA Interference
- Crop Improvement
- Chronic Kidney Disease
- Biological Control
- Drought Tolerance
- Genetic Improvement
- Precision Medicine
- Chemotherapy
- Environmental Impact
- Androgen Receptor
- Genetic Mutations
- Cardiovascular Disease
- Genomic Profiling
- Biomarkers
- Clinical Trials
- Prostate Cancer
- Immunotherapy
- Hormone Therapy
- Quality of Life
- Metastatic Prostate Cancer
- Targeted Therapy
- Clinical Guidelines
- Big Data
- QTL Mapping
- Heart Failure
- PET Imaging
- Cancer Treatment
- Economic Evaluation
- Genome Engineering
- RNA-Guided
- P450 enzymes
- Plant Breeding
- Cardiovascular Events
- Molecular Subtypes
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Clinical Trials19▲ 7.8×14 topics
- Biomarkers18▲ 7.1×16 topics
- Prostate Cancer16▲ 34×3 topics
- Genomic Profiling16▲ 42×2 topics
- Immunotherapy15▲ 5.9×14 topics
- Cardiovascular Disease14▲ 3.5×26 topics
- Hormone Therapy14▲ 45×3 topics
- Genetic Mutations13▲ 8.4×11 topics
- Quality of Life13▲ 2.5×19 topics
- Androgen Receptor12▲ 45×1 topic
- Metastatic Prostate Cancer12▲ 81×1 topic
- Environmental Impact12▲ 1.86×16 topics
- Targeted Therapy11▲ 14×5 topics
- Chemotherapy10▲ 3.8×20 topics
- Clinical Guidelines10▲ 8.9×6 topics
- Precision Medicine9▲ 5.4×7 topics
- Big Data9▲ 2.7×8 topics
- Genetic Improvement8▲ 25×3 topics
- QTL Mapping8▲ 19×6 topics
- Drought Tolerance7▲ 14×7 topics
- Heart Failure7▲ 4.5×13 topics
- Biological Control7▲ 13×7 topics
- PET Imaging7▲ 11×4 topics
- Chronic Kidney Disease6▲ 7.1×7 topics
- Cancer Treatment6▲ 7.0×6 topics
- Crop Improvement6▲ 34×2 topics
- Economic Evaluation6▲ 13×2 topics
- RNA Interference6▲ 19×2 topics
- Genome Engineering6▲ 25×1 topic
- Insecticide Resistance6▲ 20×2 topics
- RNA-Guided6▲ 25×1 topic
- Bacillus thuringiensis6▲ 60×1 topic
- P450 enzymes6▲ 60×1 topic
- Dosimetry5▲ 21×2 topics
- Plant Breeding5▲ 15×3 topics
- BRAF Mutation5▲ 20×2 topics
- Cardiovascular Events5▲ 12×4 topics
- Biotechnology5▲ 15×2 topics
- Molecular Subtypes5▲ 17×3 topics
- Marker-Assisted Selection5▲ 18×3 topics
Which research topics does Bayer (United States) publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, CRISPR and Genetic Engineering, Insect Resistance and Genetics and Health Systems, Economic Evaluations, Quality of Life.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 12 works
- 2 CRISPR and Genetic Engineering Molecular Biology 6 works
- 3 Insect Resistance and Genetics Molecular Biology 6 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 5 works
- 5 Colorectal Cancer Treatments and Studies Oncology 5 works
- 6 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 4 works
- 7 Genetics and Plant Breeding Plant Science 4 works
- 8 Economic and Financial Impacts of Cancer Economics and Econometrics 4 works
- 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
- 10 Crop Yield and Soil Fertility Agronomy and Crop Science 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Bayer (United States)'s research output changed?
Output in 2018–2022 was 4% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.